Defining the scourge of COVID-19 hyperinflammatory syndrome

Affiliations

¹ Division of Rheumatology, Children's of Alabama and Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
² Division of Rheumatology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
³ Sheffield Teaching Hospitals NHS Foundation Trust and Sheffield Children's Hospital NHS Foundation Trust, Sheffield, UK.

Randy Q Cron et al. Lancet Rheumatol. 2020 Dec.

. 2020 Dec;2(12):e727-e729.

doi: 10.1016/S2665-9913(20)30335-0. Epub 2020 Sep 29.

¹ Division of Rheumatology, Children's of Alabama and Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
² Division of Rheumatology, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
³ Sheffield Teaching Hospitals NHS Foundation Trust and Sheffield Children's Hospital NHS Foundation Trust, Sheffield, UK.

No abstract available

Figures

1. Cron RQ, Chatham WW. The rheumatologist's role in COVID-19. J Rheumatol. 2020;47:639–642. - PubMed
1. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. - PMC - PubMed
1. Webb BJ, Peltan ID, Jensen P. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol. 2020 doi: 10.1016/S2665-9913(20)30343-X. published online Sept 29. - DOI - PMC - PubMed
1. Crayne C, Cron RQ. Pediatric macrophage activation syndrome, recognizing the tip of the iceberg. Eur J Rheumatol. 2020;7(suppl 1):S13–S20. - PMC - PubMed
1. Henderson LA, Canna SW, Schulert GS. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020;72:1059–1063. - PMC - PubMed